114 related articles for article (PubMed ID: 38218121)
1. Use of oxygen-loaded nanobubbles to improve tissue oxygenation: Bone-relevant mechanisms of action and effects on osteoclast differentiation.
Knowles HJ; Vasilyeva A; Sheth M; Pattinson O; May J; Rumney RMH; Hulley PA; Richards DB; Carugo D; Evans ND; Stride E
Biomaterials; 2024 Mar; 305():122448. PubMed ID: 38218121
[TBL] [Abstract][Full Text] [Related]
2. Constant hypoxia inhibits osteoclast differentiation and bone resorption by regulating phosphorylation of JNK and IκBα.
Ma Z; Yu R; Zhao J; Sun L; Jian L; Li C; Liu X
Inflamm Res; 2019 Feb; 68(2):157-166. PubMed ID: 30604211
[TBL] [Abstract][Full Text] [Related]
3. Cellular and humoral mechanisms of osteoclast formation in Ewing's sarcoma.
Lau YS; Adamopoulos IE; Sabokbar A; Giele H; Gibbons CL; Athanasou NA
Br J Cancer; 2007 Jun; 96(11):1716-22. PubMed ID: 17533390
[TBL] [Abstract][Full Text] [Related]
4. Different Blood-Borne Human Osteoclast Precursors Respond in Distinct Ways to IL-17A.
Sprangers S; Schoenmaker T; Cao Y; Everts V; de Vries TJ
J Cell Physiol; 2016 Jun; 231(6):1249-60. PubMed ID: 26491867
[TBL] [Abstract][Full Text] [Related]
5. Activation of dimeric glucocorticoid receptors in osteoclast progenitors potentiates RANKL induced mature osteoclast bone resorbing activity.
Conaway HH; Henning P; Lie A; Tuckermann J; Lerner UH
Bone; 2016 Dec; 93():43-54. PubMed ID: 27596806
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia-inducible factor 1-alpha does not regulate osteoclastogenesis but enhances bone resorption activity via prolyl-4-hydroxylase 2.
Hulley PA; Bishop T; Vernet A; Schneider JE; Edwards JR; Athanasou NA; Knowles HJ
J Pathol; 2017 Jul; 242(3):322-333. PubMed ID: 28418093
[TBL] [Abstract][Full Text] [Related]
7. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.
Valverde P; Tu Q; Chen J
J Bone Miner Res; 2005 Sep; 20(9):1669-79. PubMed ID: 16059638
[TBL] [Abstract][Full Text] [Related]
8. Peroxidase enzymes inhibit osteoclast differentiation and bone resorption.
Panagopoulos V; Liapis V; Zinonos I; Hay S; Leach DA; Ingman W; DeNichilo MO; Atkins GJ; Findlay DM; Zannettino ACW; Evdokiou A
Mol Cell Endocrinol; 2017 Jan; 440():8-15. PubMed ID: 27836774
[TBL] [Abstract][Full Text] [Related]
9. Xanthotoxin prevents bone loss in ovariectomized mice through the inhibition of RANKL-induced osteoclastogenesis.
Dou C; Chen Y; Ding N; Li N; Jiang H; Zhao C; Kang F; Cao Z; Quan H; Luo F; Xu J; Dong S
Osteoporos Int; 2016 Jul; 27(7):2335-2344. PubMed ID: 26809192
[TBL] [Abstract][Full Text] [Related]
10. Role of Lysine-Specific Demethylase 1 in Metabolically Integrating Osteoclast Differentiation and Inflammatory Bone Resorption Through Hypoxia-Inducible Factor 1α and E2F1.
Doi K; Murata K; Ito S; Suzuki A; Terao C; Ishie S; Umemoto A; Murotani Y; Nishitani K; Yoshitomi H; Fujii T; Watanabe R; Hashimoto M; Murakami K; Tanaka M; Ito H; Park-Min KH; Ivashkiv LB; Morinobu A; Matsuda S
Arthritis Rheumatol; 2022 Jun; 74(6):948-960. PubMed ID: 35077015
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of osteoclast differentiation and bone resorption by sauchinone.
Han KY; Yang D; Chang EJ; Lee Y; Huang H; Sung SH; Lee ZH; Kim YC; Kim HH
Biochem Pharmacol; 2007 Sep; 74(6):911-23. PubMed ID: 17662251
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia-inducible factor is expressed in giant cell tumour of bone and mediates paracrine effects of hypoxia on monocyte-osteoclast differentiation via induction of VEGF.
Knowles HJ; Athanasou NA
J Pathol; 2008 May; 215(1):56-66. PubMed ID: 18283716
[TBL] [Abstract][Full Text] [Related]
13. Ferulic acid, a dietary polyphenol suppresses osteoclast differentiation and bone erosion via the inhibition of RANKL dependent NF-κB signalling pathway.
Doss HM; Samarpita S; Ganesan R; Rasool M
Life Sci; 2018 Aug; 207():284-295. PubMed ID: 29908722
[TBL] [Abstract][Full Text] [Related]
14. VEGF, FLT3 ligand, PlGF and HGF can substitute for M-CSF to induce human osteoclast formation: implications for giant cell tumour pathobiology.
Taylor RM; Kashima TG; Knowles HJ; Athanasou NA
Lab Invest; 2012 Oct; 92(10):1398-406. PubMed ID: 22906984
[TBL] [Abstract][Full Text] [Related]
15. PDK1 is important lipid kinase for RANKL-induced osteoclast formation and function via the regulation of the Akt-GSK3β-NFATc1 signaling cascade.
Xiao D; Zhou Q; Gao Y; Cao B; Zhang Q; Zeng G; Zong S
J Cell Biochem; 2020 Nov; 121(11):4542-4557. PubMed ID: 32048762
[TBL] [Abstract][Full Text] [Related]
16. Fisetin antagonizes cell fusion, cytoskeletal organization and bone resorption in RANKL-differentiated murine macrophages.
Kim YH; Kim JL; Lee EJ; Park SH; Han SY; Kang SA; Kang YH
J Nutr Biochem; 2014 Mar; 25(3):295-303. PubMed ID: 24524902
[TBL] [Abstract][Full Text] [Related]
17. Metformin Reduces Bone Resorption in Apical Periodontitis Through Regulation of Osteoblast and Osteoclast Differentiation.
Hong CY; Lin SK; Wang HW; Shun CT; Yang CN; Lai EH; Cheng SJ; Chen MH; Yang H; Lin HY; Wu FY; Kok SH
J Endod; 2023 Sep; 49(9):1129-1137. PubMed ID: 37454872
[TBL] [Abstract][Full Text] [Related]
18. MMP-13 stimulates osteoclast differentiation and activation in tumour breast bone metastases.
Pivetta E; Scapolan M; Pecolo M; Wassermann B; Abu-Rumeileh I; Balestreri L; Borsatti E; Tripodo C; Colombatti A; Spessotto P
Breast Cancer Res; 2011 Oct; 13(5):R105. PubMed ID: 22032644
[TBL] [Abstract][Full Text] [Related]
19. The active metabolite of leflunomide, A771726, inhibits both the generation of and the bone-resorbing activity of osteoclasts by acting directly on cells of the osteoclast lineage.
Kobayashi Y; Ueyama S; Arai Y; Yoshida Y; Kaneda T; Sato T; Shin K; Kumegawa M; Hakeda Y
J Bone Miner Metab; 2004; 22(4):318-28. PubMed ID: 15221489
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia is a major stimulator of osteoclast formation and bone resorption.
Arnett TR; Gibbons DC; Utting JC; Orriss IR; Hoebertz A; Rosendaal M; Meghji S
J Cell Physiol; 2003 Jul; 196(1):2-8. PubMed ID: 12767036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
